Montelukast Sandoz (Montelukast)

Montelukast works by selectively blocking the cysteinyl leukotriene receptor CysLT1. This inhibition prevents leukotrienes D4, E4 and F4 from triggering bronchial smooth‑muscle contraction, mucus production, and inflammatory cell recruitment, thereby reducing airway narrowing and allergic symptoms.

The appropriate dose of Montelukast Sandoz is determined by the prescribing healthcare professional based on the patient’s age, condition severity and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Montelukast use in pregnancy and lactation are limited. Healthcare providers weigh potential benefits against risks before prescribing it to pregnant or nursing women. Patients should discuss any concerns with their doctor before starting therapy.

To order Montelukast Sandoz, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids and long‑acting beta‑agonists. It is particularly useful for patients with allergic components or exercise‑induced bronchoconstriction, but it is not a rescue medication for acute attacks.

Montelukast Sandoz should be stored at room temperature, below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Montelukast Sandoz is taken orally, usually once daily in the evening, with or without food. The tablet should be swallowed whole with a glass of water. Patients must follow the dosing schedule prescribed by their healthcare provider.

Serious risks include neuropsychiatric events such as mood changes, depression or suicidal thoughts, as well as rare allergic reactions like angioedema and anaphylaxis. Any sudden or severe symptoms should prompt immediate medical attention.

Montelukast Sandoz should be avoided in individuals with known hypersensitivity to montelukast or any of its tablet components. It is also not suitable as a rescue medication for acute asthma attacks and should be used with caution in patients with severe hepatic impairment.